大塚ホールディングスの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/05/24 | 4,498 | 4,509 | 4,462 | 4,467 | -36 | -0.8% | 819,300 |
| 2022/05/23 | 4,490 | 4,522 | 4,453 | 4,503 | +62 | +1.4% | 1,019,700 |
| 2022/05/20 | 4,474 | 4,494 | 4,435 | 4,441 | -44 | -1% | 1,392,100 |
| 2022/05/19 | 4,423 | 4,503 | 4,395 | 4,485 | -65 | -1.4% | 1,135,400 |
| 2022/05/18 | 4,486 | 4,555 | 4,478 | 4,550 | +103 | +2.3% | 1,412,700 |
| 2022/05/17 | 4,461 | 4,474 | 4,415 | 4,447 | +25 | +0.6% | 1,416,400 |
| 2022/05/16 | 4,350 | 4,504 | 4,350 | 4,422 | +106 | +2.5% | 1,095,400 |
| 2022/05/13 | 4,400 | 4,420 | 4,250 | 4,316 | -80 | -1.8% | 1,840,300 |
| 2022/05/12 | 4,396 | 4,417 | 4,339 | 4,396 | -25 | -0.6% | 855,800 |
| 2022/05/11 | 4,406 | 4,450 | 4,401 | 4,421 | -20 | -0.5% | 895,000 |
| 2022/05/10 | 4,424 | 4,451 | 4,405 | 4,441 | +2 | ±0% | 870,800 |
| 2022/05/09 | 4,495 | 4,506 | 4,419 | 4,439 | -84 | -1.9% | 936,900 |
| 2022/05/06 | 4,444 | 4,532 | 4,411 | 4,523 | +100 | +2.3% | 1,517,200 |
| 2022/05/02 | 4,351 | 4,430 | 4,303 | 4,423 | +60 | +1.4% | 1,225,600 |
| 2022/04/28 | 4,233 | 4,376 | 4,191 | 4,363 | +168 | +4% | 1,398,100 |
| 2022/04/27 | 4,239 | 4,239 | 4,165 | 4,195 | -85 | -2% | 1,497,700 |
| 2022/04/26 | 4,245 | 4,303 | 4,237 | 4,280 | +37 | +0.9% | 1,065,800 |
| 2022/04/25 | 4,217 | 4,254 | 4,195 | 4,243 | +10 | +0.2% | 742,900 |
| 2022/04/22 | 4,228 | 4,243 | 4,198 | 4,233 | -17 | -0.4% | 713,100 |
| 2022/04/21 | 4,215 | 4,282 | 4,173 | 4,250 | +75 | +1.8% | 895,500 |
| 2022/04/20 | 4,122 | 4,177 | 4,110 | 4,175 | +47 | +1.1% | 670,900 |
| 2022/04/19 | 4,134 | 4,151 | 4,108 | 4,128 | +12 | +0.3% | 553,700 |
| 2022/04/18 | 4,171 | 4,184 | 4,081 | 4,116 | -100 | -2.4% | 514,900 |
| 2022/04/15 | 4,203 | 4,236 | 4,174 | 4,216 | -24 | -0.6% | 475,400 |
| 2022/04/14 | 4,193 | 4,258 | 4,190 | 4,240 | +41 | +1% | 481,800 |
| 2022/04/13 | 4,126 | 4,213 | 4,125 | 4,199 | +22 | +0.5% | 856,900 |
| 2022/04/12 | 4,221 | 4,235 | 4,168 | 4,177 | -61 | -1.4% | 707,300 |
| 2022/04/11 | 4,230 | 4,247 | 4,202 | 4,238 | +1 | ±0% | 810,600 |
| 2022/04/08 | 4,282 | 4,282 | 4,228 | 4,237 | -4 | -0.1% | 1,332,000 |
| 2022/04/07 | 4,180 | 4,248 | 4,159 | 4,241 | +59 | +1.4% | 934,800 |
| 2022/04/06 | 4,207 | 4,225 | 4,160 | 4,182 | -63 | -1.5% | 1,150,100 |
| 2022/04/05 | 4,300 | 4,303 | 4,210 | 4,245 | -36 | -0.8% | 1,024,100 |
| 2022/04/04 | 4,260 | 4,302 | 4,232 | 4,281 | +59 | +1.4% | 649,000 |
| 2022/04/01 | 4,211 | 4,225 | 4,149 | 4,222 | -10 | -0.2% | 858,500 |
| 2022/03/31 | 4,242 | 4,307 | 4,232 | 4,232 | -38 | -0.9% | 1,549,200 |
| 2022/03/30 | 4,300 | 4,319 | 4,229 | 4,270 | -1 | ±0% | 871,600 |
| 2022/03/29 | 4,241 | 4,272 | 4,219 | 4,271 | +38 | +0.9% | 865,800 |
| 2022/03/28 | 4,258 | 4,259 | 4,211 | 4,233 | -34 | -0.8% | 558,400 |
| 2022/03/25 | 4,268 | 4,272 | 4,208 | 4,267 | +20 | +0.5% | 797,600 |
| 2022/03/24 | 4,265 | 4,267 | 4,211 | 4,247 | -23 | -0.5% | 909,200 |
| 2022/03/23 | 4,200 | 4,284 | 4,185 | 4,270 | +122 | +2.9% | 1,137,000 |
| 2022/03/22 | 4,188 | 4,207 | 4,135 | 4,148 | -18 | -0.4% | 1,693,900 |
| 2022/03/18 | 4,174 | 4,194 | 4,105 | 4,166 | +41 | +1% | 1,852,500 |
| 2022/03/17 | 4,108 | 4,130 | 4,067 | 4,125 | +101 | +2.5% | 1,446,900 |
| 2022/03/16 | 4,030 | 4,060 | 4,023 | 4,024 | +51 | +1.3% | 925,700 |
| 2022/03/15 | 3,935 | 3,987 | 3,920 | 3,973 | +50 | +1.3% | 662,700 |
| 2022/03/14 | 3,965 | 4,023 | 3,916 | 3,923 | -6 | -0.2% | 972,400 |
| 2022/03/11 | 3,947 | 3,966 | 3,901 | 3,929 | -53 | -1.3% | 1,360,800 |
| 2022/03/10 | 3,897 | 3,997 | 3,879 | 3,982 | +100 | +2.6% | 1,425,100 |
| 2022/03/09 | 3,845 | 3,909 | 3,841 | 3,882 | +45 | +1.2% | 1,268,000 |
801～
850
件表示中 / 3596件
類似銘柄と比較する
現在ご覧いただいている「大塚ＨＤ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 大塚ＨＤ | 789,300円 | +2.2% | +28.0% | 1.77% | 12.63倍 | 1.53倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界９０カ所に工場 |
| 武 田 | 440,200円 | -1.1% | +75.3% | 4.54% | 30.49倍 | 1.00倍 |
|
国内製薬首位。がん、中枢神経、消化器、希少疾患等に重点。巨額買収で世界売上上位１０強入り |
| 第一三共 | 358,800円 | +6.0% | +4.0% | 2.17% | 22.14倍 | 4.09倍 |
|
国内製薬大手。循環器と感染症薬強い。英アストラゼネカ社と提携し、がん領域の開拓中 |
| アステラス薬 | 162,900円 | +0.9% | +380.2% | 4.79% | 22.44倍 | 1.93倍 |
|
医薬品国内２位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
| 塩野義 | 254,000円 | +20.9% | +10.6% | 2.60% | 12.01倍 | 1.59倍 |
|
抗ＨＩＶ薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
市場注目の銘柄
チャート関連のコラム
